2022 Q1 Form 10-K Financial Statement

#000143774922015612 Filed on June 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $8.126M $35.97M $9.438M
YoY Change -13.9% 11.2% 9.31%
Cost Of Revenue $5.232M $22.40M $6.668M
YoY Change -21.54% 5.53% 20.14%
Gross Profit $2.894M $13.57M $2.771M
YoY Change 4.44% 22.03% -10.15%
Gross Profit Margin 35.61% 37.72% 29.36%
Selling, General & Admin $2.301M $10.28M $2.675M
YoY Change -13.98% -1.1% -2.37%
% of Gross Profit 79.51% 75.78% 96.54%
Research & Development $229.0K $712.0K $120.0K
YoY Change 90.83% 11.42% 0.0%
% of Gross Profit 7.91% 5.25% 4.33%
Depreciation & Amortization $397.0K $1.599M $408.0K
YoY Change -2.7% -8.52% -13.19%
% of Gross Profit 13.72% 11.79% 14.72%
Operating Expenses $2.530M $10.99M $2.795M
YoY Change -9.48% -0.37% -2.27%
Operating Profit $364.0K $2.574M -$24.00K
YoY Change -1616.67% 2964.29% -110.71%
Interest Expense -$80.00K $392.0K -$176.0K
YoY Change -54.55% -28.73% 35.38%
% of Operating Profit -21.98% 15.23%
Other Income/Expense, Net -$392.0K
YoY Change -146.72%
Pretax Income $284.0K $2.182M -$201.0K
YoY Change -241.29% 136.4% -301.0%
Income Tax $7.000K $28.00K $0.00
% Of Pretax Income 2.46% 1.28%
Net Earnings $277.0K $2.154M -$200.0K
YoY Change -238.5% 134.13% -265.29%
Net Earnings / Revenue 3.41% 5.99% -2.12%
Basic Earnings Per Share $0.35
Diluted Earnings Per Share $44.71K $0.35 -$32.95K
COMMON SHARES
Basic Shares Outstanding 6.194M 6.157M
Diluted Shares Outstanding 6.168M

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.589M $2.589M $3.767M
YoY Change -31.27% -31.27% 55.66%
Cash & Equivalents $2.589M $3.767M
Short-Term Investments
Other Short-Term Assets $545.0K $545.0K $488.0K
YoY Change 11.68% 11.68% -2.4%
Inventory $9.466M $9.466M $8.415M
Prepaid Expenses
Receivables $3.664M $3.664M $2.436M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.26M $16.26M $15.11M
YoY Change 7.67% 7.67% 2.57%
LONG-TERM ASSETS
Property, Plant & Equipment $11.89M $15.67M $12.14M
YoY Change -2.07% 0.12% -6.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $109.0K $109.0K $120.0K
YoY Change -9.17% -9.17% -34.43%
Total Long-Term Assets $15.78M $15.78M $15.77M
YoY Change 0.05% 0.05% -7.54%
TOTAL ASSETS
Total Short-Term Assets $16.26M $16.26M $15.11M
Total Long-Term Assets $15.78M $15.78M $15.77M
Total Assets $32.05M $32.05M $30.88M
YoY Change 3.78% 3.78% -2.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.362M $2.362M $2.287M
YoY Change 3.28% 3.28% 7.02%
Accrued Expenses $1.412M $1.805M $1.412M
YoY Change 0.0% 52.06% 66.31%
Deferred Revenue $164.0K $124.0K
YoY Change 32.26% -62.08%
Short-Term Debt $0.00 $0.00 $1.000M
YoY Change -100.0% -100.0% -50.98%
Long-Term Debt Due $490.0K $490.0K $2.210M
YoY Change -77.83% -59.5% -17.81%
Total Short-Term Liabilities $4.821M $4.821M $5.808M
YoY Change -16.99% -16.99% -8.66%
LONG-TERM LIABILITIES
Long-Term Debt $4.336M $4.336M $4.823M
YoY Change -10.1% -10.1% -19.74%
Other Long-Term Liabilities $15.00K $3.401M $32.00K
YoY Change -53.13% 6.05% -40.74%
Total Long-Term Liabilities $4.351M $7.737M $4.855M
YoY Change -10.38% -3.65% -19.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.821M $4.821M $5.808M
Total Long-Term Liabilities $4.351M $7.737M $4.855M
Total Liabilities $12.56M $12.56M $13.84M
YoY Change -9.25% -9.25% -13.19%
SHAREHOLDERS EQUITY
Retained Earnings -$14.19M -$16.35M
YoY Change -13.18% -5.33%
Common Stock $124.0K $122.0K
YoY Change 1.64% 1.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.49M $19.49M $17.04M
YoY Change
Total Liabilities & Shareholders Equity $32.05M $32.05M $30.88M
YoY Change 3.78% 3.78% -2.86%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income $277.0K $2.154M -$200.0K
YoY Change -238.5% 134.13% -265.29%
Depreciation, Depletion And Amortization $397.0K $1.599M $408.0K
YoY Change -2.7% -8.52% -13.19%
Cash From Operating Activities $1.035M $2.379M $1.480M
YoY Change -30.07% -0.88% 42.31%
INVESTING ACTIVITIES
Capital Expenditures -$525.0K -$1.270M -$180.0K
YoY Change 191.67% 67.11% 350.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$525.0K -$1.270M -$180.0K
YoY Change 191.67% 67.11% 350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -219.0K -$2.287M -860.0K
YoY Change -74.53% 688.62% 352.63%
NET CHANGE
Cash From Operating Activities 1.035M $2.379M 1.480M
Cash From Investing Activities -525.0K -$1.270M -180.0K
Cash From Financing Activities -219.0K -$2.287M -860.0K
Net Change In Cash 291.0K -$1.178M 440.0K
YoY Change -33.86% -187.26% -45.68%
FREE CASH FLOW
Cash From Operating Activities $1.035M $2.379M $1.480M
Capital Expenditures -$525.0K -$1.270M -$180.0K
Free Cash Flow $1.560M $3.649M $1.660M
YoY Change -6.02% 15.47% 53.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Auditor Firm
AuditorFirmId
248
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
67000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3664000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2436000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
9466000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3517000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
109000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
120000 USD
CY2022Q1 us-gaap Assets
Assets
32045000 USD
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6202223
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6202223
CY2021Q1 us-gaap Inventory Net
InventoryNet
8415000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
545000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
488000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
16264000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
15106000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11885000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12136000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3787000 USD
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6116073
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6116073
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2018Q3 cyan Debt Covenant Minimum Current Ratio
DebtCovenantMinimumCurrentRatio
1.50 pure
CY2016Q2 cyan Purchase Obligation Agreement Term
PurchaseObligationAgreementTerm
P10Y
CY2022Q1 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2 pure
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2589000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3767000 USD
CY2021Q1 us-gaap Assets
Assets
30879000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2362000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2287000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1412000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
844000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
164000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
124000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
393000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
343000 USD
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1000000 USD
CY2022Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
490000 USD
CY2021Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
1210000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4821000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5808000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4336000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4823000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3386000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3175000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
12558000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
13838000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
124000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
122000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33557000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33267000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14194000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16348000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
19487000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
17041000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32045000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30879000 USD
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35968000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32345000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31899000 USD
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22402000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21228000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19199000 USD
CY2022 us-gaap Gross Profit
GrossProfit
13566000 USD
CY2021 us-gaap Gross Profit
GrossProfit
11117000 USD
CY2020 us-gaap Gross Profit
GrossProfit
12700000 USD
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5367000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4876000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5281000 USD
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4913000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5518000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5758000 USD
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
712000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
639000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
608000 USD
CY2022 us-gaap Operating Expenses
OperatingExpenses
10992000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
11033000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
11647000 USD
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2574000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
84000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1053000 USD
CY2022 us-gaap Interest Expense
InterestExpense
392000 USD
CY2021 us-gaap Interest Expense
InterestExpense
550000 USD
CY2020 us-gaap Interest Expense
InterestExpense
657000 USD
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1389000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-392000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
839000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-657000 USD
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2182000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
923000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
396000 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2154000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
920000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
387000 USD
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6157000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6070000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5956000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6168000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6079000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5959000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
14909000 USD
CY2020 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 USD
CY2020 cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
-320000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-31000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
387000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15846000 USD
CY2021 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000 USD
CY2021 cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
0 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7000 USD
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
56000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
920000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
17041000 USD
CY2022 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-52000 USD
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
186000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2154000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
19487000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2154000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
920000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
387000 USD
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1599000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1748000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1934000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1389000 USD
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
21000 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
64000 USD
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
57000 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
90000 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
80000 USD
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
322000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
317000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
294000 USD
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
344000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
214000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
577000 USD
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000 USD
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1263000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
328000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
172000 USD
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
717000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1238000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1621000 USD
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
74000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-41000 USD
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-358000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2785000 USD
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
568000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2210000 USD
CY2022Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
4448000 USD
CY2021Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
4963000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
112000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
140000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4336000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4823000 USD
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
112000 USD
CY2021 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
38000 USD
CY2020 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
247000 USD
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1000000 USD
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
57000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
140000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-143000 USD
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
40000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-203000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-299000 USD
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-331000 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-320000 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-289000 USD
CY2022 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-18000 USD
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-22000 USD
CY2020 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2379000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2400000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1243000 USD
CY2022 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
1270000 USD
CY2021 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
760000 USD
CY2020 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
224000 USD
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1270000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-760000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-224000 USD
CY2022 cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
USD
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1000000 USD
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
USD
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-500000 USD
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
USD
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1500000 USD
CY2022 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
USD
CY2021 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
1381000 USD
CY2020 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
USD
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
735000 USD
CY2021 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
670000 USD
CY2020 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
611000 USD
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52000 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31000 USD
CY2022 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
USD
CY2021 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
68000 USD
CY2020 cyan Proceeds From Issuance Of Common Stock And Stock Options Exercised
ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised
4000 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2287000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-290000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
558000 USD
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1178000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1350000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1577000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3767000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2417000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
840000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2589000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3767000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
490000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
287000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1304000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
321000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
339000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2197000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
4938000 USD
CY2022Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
108000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2417000 USD
CY2022 us-gaap Interest Paid Net
InterestPaidNet
342000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
446000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
618000 USD
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2589000 USD
CY2022Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
11443000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3767000 USD
CY2021Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
9298000 USD
CY2022Q1 cyan Long Term Debt And Capital Lease Obligations Current And Noncurrent
LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent
3938000 USD
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.  Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.  Actual results could differ from those estimates and assumptions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1992000 USD
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Concentration Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Company maintains its cash accounts in banks located in Hawaii, which are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to <em style="font: inherit;">$250,000</em> per bank.  The Company had cash balances at <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021</em> that exceeded the balance insured by the FDIC by $2,089,000 and $3,267,000, respectively.  A significant portion of revenues and accounts receivables are derived from a few major customers. For the year ended <em style="font: inherit;"> March 31, 2022, </em><span style="-sec-ix-hidden:c84894756">two</span> customers individually accounted for 22% and 19% of the Company’s total net sales and for the year ended <em style="font: inherit;"> March 31, 2021, </em><span style="-sec-ix-hidden:c84894765">two</span> customers individually accounted for 19% and 17% of the Company’s total net sales. Two and <span style="-sec-ix-hidden:c84894770"><span style="-sec-ix-hidden:c84894771">three</span></span> customers accounted for 63% and 57%, respectively, of the Company’s accounts receivable balance as of <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2089000 USD
CY2021Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3267000 USD
CY2021Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
16000 USD
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
488000 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
195000 USD
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
211000 USD
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1458000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
86000 USD
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55000 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
251000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2116000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1490000 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
547000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2868000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3206000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4595000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4423000 USD
CY2022Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
513000 USD
CY2021Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
239000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
9466000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
8415000 USD
CY2022 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
CY2021 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
110000 USD
CY2020 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
CY2022 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
136000 USD
CY2021 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
179000 USD
CY2020 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
343000 USD
CY2022Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
392000 USD
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
408000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34131000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24339000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22740000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35376000 USD
CY2022Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
848000 USD
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
745000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11885000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12136000 USD
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
21000 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
64000 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1599000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1748000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1934000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
490000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
213000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
139000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1412000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
844000 USD
CY2022 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
73000 USD
CY2021 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
50000 USD
CY2020 cyan Operating Leases Expense Contingent Rentals
OperatingLeasesExpenseContingentRentals
49000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y2M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072 pure
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
603000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y6M
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
591000 USD
CY2022Q1 cyan Operating Lease Rightofuse Asset Before Accumulated Amortization
OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization
4720000 USD
CY2021Q1 cyan Operating Lease Rightofuse Asset Before Accumulated Amortization
OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization
4128000 USD
CY2022Q1 cyan Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
933000 USD
CY2021Q1 cyan Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
611000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3787000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3517000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
393000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
343000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3386000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3175000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3779000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3518000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
646000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
480000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
480000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
446000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
437000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3197000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5686000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1907000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3779000 USD
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
713000 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
616000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
623000 USD
CY2022Q1 us-gaap Purchase Obligation
PurchaseObligation
1105000 USD
CY2021Q1 us-gaap Purchase Obligation
PurchaseObligation
1005000 USD
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
825000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1950000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1283313
CY2022Q1 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Shares Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding
266965
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
539800
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M24D
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
675300 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.11
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2112
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.08
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
104388
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.58
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
120000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.53
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
318300
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.08
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
130000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.35
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
19000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.59
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
55000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.13
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
374300
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
129700 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.96
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.21
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
166800
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.84
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
252500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.34
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
159650 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
110833
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.35
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
44816 USD
CY2022Q1 us-gaap Share Price
SharePrice
3.37
CY2021Q1 us-gaap Share Price
SharePrice
3.30
CY2020Q1 us-gaap Share Price
SharePrice
2.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000 USD
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
125000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.19
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.60
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
33333
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.20
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
141667
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.33
CY2022 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
80000 USD
CY2021 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
155000 USD
CY2020 cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
5000 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
40000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
6000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
169000 USD
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
252500
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.34
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
110833
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.60
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.20
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5823 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5444 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5061 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0106 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0040 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0147 pure
CY2022 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P3Y
CY2021 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P3Y
CY2020 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod
P0Y
CY2022 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0 pure
CY2021 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0 pure
CY2020 cyan Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y10M24D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 cyan Sharesauthorized
Sharesauthorized
60000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2154000 USD
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6157000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11000
CY2022 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
2154000 USD
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6168000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2021 us-gaap Net Income Loss
NetIncomeLoss
920000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6070000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2021 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8000
CY2021 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
920000 USD
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6079000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020 us-gaap Net Income Loss
NetIncomeLoss
387000 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5956000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000
CY2020 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
387000 USD
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5959000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35968000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32345000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31899000 USD
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-0 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-3000 USD
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
28000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000 USD
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9000 USD
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-0 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-0 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-0 USD
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-0 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-0 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-0 USD
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-0 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-0 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 USD
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
591000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
263000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
114000 USD
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
16000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
11000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13000 USD
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-557000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
17000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-159000 USD
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2000 USD
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-0 USD
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-0 USD
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
32000 USD
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3000 USD
CY2022 cyan Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount
EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount
34000 USD
CY2021 cyan Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount
EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount
27000 USD
CY2020 cyan Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount
EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount
0 USD
CY2022 cyan Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount
EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount
0 USD
CY2021 cyan Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount
EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount
298000 USD
CY2020 cyan Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount
EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount
0 USD
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
38000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 USD
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3140000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4009000 USD
CY2020Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3703000 USD
CY2022Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
175000 USD
CY2021Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
136000 USD
CY2020Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
492000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
251000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
136000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
136000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28000 USD
CY2022Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
0 USD
CY2021Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
0 USD
CY2020Q1 cyan Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
3000 USD
CY2022Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
1025000 USD
CY2021Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
1002000 USD
CY2020Q1 cyan Deferred Tax Assets Operating Lease Right Of Use Assets
DeferredTaxAssetsOperatingLeaseRightOfUseAssets
1108000 USD
CY2022Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
27000 USD
CY2021Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
34000 USD
CY2020Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
25000 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4646000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5345000 USD
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5495000 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2473000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3030000 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3013000 USD
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2173000 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2315000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2482000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1027000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1002000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1106000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1146000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1313000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1376000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2173000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2315000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2482000 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13099000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD

Files In Submission

Name View Source Status
0001437749-22-015612-index-headers.html Edgar Link pending
0001437749-22-015612-index.html Edgar Link pending
0001437749-22-015612.txt Edgar Link pending
0001437749-22-015612-xbrl.zip Edgar Link pending
cyan-20220331.xsd Edgar Link pending
cyan-20220331_cal.xml Edgar Link unprocessable
cyan-20220331_def.xml Edgar Link unprocessable
cyan-20220331_lab.xml Edgar Link unprocessable
cyan-20220331_pre.xml Edgar Link unprocessable
cyan20220331_10k.htm Edgar Link pending
cyan20220331_10k_htm.xml Edgar Link completed
ex_385967.htm Edgar Link pending
ex_385968.htm Edgar Link pending
ex_385969.htm Edgar Link pending
ex_385970.htm Edgar Link pending
ex_385971.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending